Is Elle really a “white horse” in the whirlpool? A whole year’s growth exceeds 147%, medical disputes occur frequently under the rapid expansion

A few days ago, the event of “Aifen’s medical trouble” in Aier ophthalmology continued to ferment. On December 30, 2020, AI Fen, director of the emergency department of Wuhan Central Hospital, revealed on his microblog that the retina fell off after lens replacement surgery in Aier Ophthalmology, which caused a hot discussion on the Internet. Is it Aier Ophthalmology’s later statement that “all operations are in line with medical standards” or aifensheng’s statement that Aier ophthalmology “evades the heavy and shirks the responsibility”? The facts are not clear. < / P > < p > on January 7, a reporter from China Times called the relevant person in charge of Aier ophthalmology securities department to inquire about the latest progress of the incident, and the other side said: “we are trying to communicate with doctor Aier.” As for whether a third-party appraisal agency has been involved, he responded that this is not something that can be done unilaterally, because it needs a third-party agency recognized by both sides and the cooperation of Aifen. < / P > < p > on January 4, the first trading day after the storm, the stock price of Aier Eye dropped nearly 9%. However, the decline lasted only one day, and many retail investors yelled “bottom hunting”. As of January 7, the stock price of Aier Eye broke a new high. However, on January 8, the stock price rebounded. As of the press release, the stock price has dropped by more than 5%. The stock price of Aier ophthalmology has a rapid momentum in 2020, with a year-on-year increase of more than 140%. The current market value has exceeded 300 billion yuan. < / P > < p > under this event, investors will focus on the performance of Aier Eye terminal market again. Can the technology and service level of hospitals keep up with the expansion of Aier Eye? Blue chip “white horse stock” really does not “bury thunder”? < / P > < p > however, at present, the communication between Aier ophthalmology and Aifen seems not smooth. At noon on January 7, Aifen once again denounced Wuhan Aier ophthalmic hospital on its micro blog, pointing out that it had concealed, forged and destroyed medical documents. It is understood that the medical mediation commission of Wuchang District of Wuhan city is intervening in the mediation of the incident.

the cause of widespread concern has also been attributed to COVID-19’s “whistle man” identity tag of Wuhan’s anti epidemic doctor, AI Fen. With the continuous spread of the incident, its micro-blog account “emergency sunflower AI Fen” currently has 2 million 190 thousand fans. AI Fen sharp words: “Ai Er Ophthalmology’s behavior is not only a mistake, but no medical ethics.” In her opinion, Wuhan Aier Eye Hospital ignored her own fundus diseases and retinal problems, and she repeatedly stressed that she had not significantly improved after surgery, but still did not attract her attention, and missed the best opportunity for treatment. < / P > < p > looking back at the beginning and end of the incident, in May 2020, Aifen felt that her eyesight had decreased. After being introduced, she went to Wuhan Aier Eye Hospital. The attending doctor was Wang Yong, vice president of Wuhan Aier Eye Hospital. She diagnosed that her right eye was suffering from cataract, and then Aifen accepted the operation of implanting multifocal lens in her right eye. On October 24, after examination in Wuhan Central Hospital, AI Fen found that his right eye had retinal detachment and extensive degeneration around the retina, so he operated on retinal detachment and almost lost his vision after operation. < / P > < p > for this operation, Aier Eye Hospital Group issued a verification report on January 4, admitting that Wuhan Aier Eye Hospital has problems such as incomplete postoperative review records, and hopes to apply with Aifen to a third-party organization for examination and identification. Earlier, on the evening of December 31, 2020, Wuhan Aier ophthalmology issued a statement saying that Dr. Aifen’s right eye was high myopia complicated with cataract. After the hospital self-examination, the preoperative examination, operation and postoperative review of the operation were in line with the medical standards. < p > < p > when AI Er ophthalmology department mentioned the above verification report to the China Times reporter, it said: “our position has been very clear. Now it’s time to see what doctor AI thinks and how to deal with it. It’s a matter after consultation and appraisal.” “The other side said:” retinal detachment, eye disease does bring pain to the patient, we can understand, but we want her to be more rational. ” < / P > < p > is Ivan’s mesh detachment caused by cataract surgery? A senior ophthalmologist said that cataract surgery does cause retinal detachment. However, the retinal detachment caused by cataract surgery occurs in a short time after surgery. If the retinal detachment occurs only five months after surgery, it will not have a strong correlation with surgery at least. These will have to wait for the conclusion of subsequent official medical appraisal. < / P > < p > this incident has made Aier ophthalmology fall into a crisis of trust. With the rapid expansion of its territory, hidden dangers such as high reputation risk, doctors’ technical level, management and service ability appear. The incident is pending, and there are voices in the industry that this episode is in danger for Aier Ophthalmology, which is basically oriented to the good. If it can be handled well, it will win the public trust again. < / P > < p > Aier ophthalmology was founded in 2002. In 2009, Aier ophthalmology became one of the first batch of enterprises listed on the growth enterprise market. It is also the first private hospital listed in China. It is known as “the first share of Ophthalmology” and “ophthalmology Maotai”. < / P > < p > in recent years, the market scale of Aier ophthalmology has been expanding, and its performance has also maintained a certain growth rate. In addition, the optimistic judgment on the prospect of Ophthalmology track has made Aier ophthalmology more popular in the stock market. Compared with the ratio of 1.32 yuan / share on the first day of listing, the share price of Aier ophthalmology has increased by more than 50 times, and the market value has increased by more than 40 times from about 7 billion yuan at the initial stage of listing. In the Hurun 100 rich list released in October 2019, the wealth of Chen bang, chairman of Aier Ophthalmology, rose to 53 billion, taking over Hunan’s richest man for the first time. < p > < p > Chen Bang’s capital operation means are quite sophisticated. In 2014, Aier Eye introduced Aier industrial fund to speed up its territory expansion. On the one hand, it carried out network construction through the self owned funds of listed companies; on the other hand, it accelerated the “in vitro cultivation” of National Eye hospitals through the leverage brought by industrial fund, and then acquired after cultivation. < / P > < p > the acquisition strategy has obvious effect, and the revenue and net profit of Aier ophthalmology have maintained rapid growth. The data shows that from 2009 to 2019, the revenue of Aier ophthalmology has increased from 606 million to 9.99 billion yuan, and the net profit has increased from 90 million to 1.431 billion yuan. Refractive items, cataract items, glasses and other optometry services of myopia surgery accounted for 35.34%, 17.62% and 19.32% of the company’s total revenue respectively. < / P > < p > at present, Aier ophthalmology has become the largest ophthalmic chain medical institution in the world, and its domestic chain ophthalmic medical institutions have grown from more than a dozen when they were just listed to more than 400 now, with more than 5000 ophthalmologists. In order to enter the international market, Aier Eye has also acquired ophthalmic companies in the United States, the largest ophthalmic chain in Europe and head ophthalmic medical group in Southeast Asia. < / P > < p > the goodwill risk appears with the pace of expansion. According to the third quarter report of 2020, the goodwill balance of Aier ophthalmology at the end of the period is 4.126 billion yuan, an increase of 56.41% over the beginning of the year, accounting for 43.43% of the company’s net assets. < / P > < p > in fact, there has been more than one medical accident in recent years similar to the “Aifen incident”. On January 8, the reporter of Huaxia times inquired the China judicial documents website and found that since 2015, there have been more than 70 civil cases involving medical damage liability disputes of Aier Ophthalmology, and the amount of compensation for patients ranges from tens of thousands to hundreds of thousands of yuan, involving Aier ophthalmic hospitals in Huanggang City of Hubei Province, Yuxi City of Yunnan Province, Taiyuan city of Shanxi Province, etc. < / P > < p > among them, a second instance document issued on March 26, 2020 contains the following contents: Yuxi Aier Eye Hospital violated the diagnosis and treatment nursing norms in the process of providing medical services for Su yongxue, such as incomplete operation records and no description of vitrectomy; the above-mentioned fault of Yuxi Aier eye hospital is related to the phacoemulsification of Su yongxue’s right eye There is a causal relationship between the damage of visual acuity, light perception and inaccurate light location in the right eye after phacoemulsification + intraocular lens implantation + vitrectomy < / P > < p > as for when the stalemate between the two sides will be eased and how to predict the final outcome, Aier ophthalmology seems to have an attitude of “let the bullet fly for a while”. The relevant person in charge told the China Times: “I believe this matter will be successfully solved in the end.” < / P > < p > Disclaimer: the purpose of this article reprinted by CNFC is to convey more information, and it does not represent the opinions and positions of CNFC. The content of this article is for reference only, and does not constitute an investment proposal. Investors operate on this basis at their own risk. < p > < p > Chinanet is a state key news website under the leadership of the Information Office of the State Council and the management of China foreign language publishing and Distribution Bureau. Through 11 versions in 10 languages, the website publishes information 24 hours a day. It is an important window for China to carry out international communication and information exchange.